$4.56
-0.130 (-2.77%)
At Close: Jun 03, 2026
LifeMD Appoints Umesh Sripad as Chief Technology Officer
08:05am, Monday, 01'st Jun 2026
Seasoned Technology Executive Brings More Than Two Decades of Large-Scale Digital Transformation Experience to Support LifeMD's Next Phase of Growth Seasoned Technology Executive Brings More Than Two
LifeMD to Participate in Upcoming Investor Conferences
08:00am, Friday, 15'th May 2026
NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading platform for virtual primary care services, today announced that management will be participating in two upcoming inve
LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript
11:01pm, Wednesday, 06'th May 2026
LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript
LifeMD, Inc. (LFMD) Reports Q1 Loss, Tops Revenue Estimates
07:35pm, Wednesday, 06'th May 2026
LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to earnings of $0.01 per share a year ago.
LifeMD Reports First Quarter 2026 Results
04:05pm, Wednesday, 06'th May 2026
First quarter 2026 revenue of $50.2 million and adjusted EBITDA loss of $4.5 million, above and in line, respectively, with the Company's guidance. Gross margin increased approximately 420 basis point
LifeMD to Report First Quarter 2026 Financial Results on May 6
08:00am, Monday, 27'th Apr 2026
NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ende
LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?
09:01am, Tuesday, 21'st Apr 2026
LifeMD (LFMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
LifeMD® Now Offering Eli Lilly and Company's Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management
08:15am, Friday, 10'th Apr 2026
LifeMD expands its weight management program with the addition of Foundayo, offering eligible patients an oral alternative to injectable GLP-1 therapies through LillyDirect® LifeMD expands its weight
LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program
08:45am, Tuesday, 31'st Mar 2026
Delivering up to $1,200 in annual patient savings on branded GLP-1 therapy, expanding LifeMD's collaboration with Novo Nordisk Delivering up to $1,200 in annual patient savings on branded GLP-1 therap
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
04:05pm, Tuesday, 24'th Mar 2026
NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividen
LifeMD, Inc. (NASDAQ:LFMD) Given Average Recommendation of “Moderate Buy” by Brokerages
02:24am, Tuesday, 17'th Mar 2026
Shares of LifeMD, Inc. (NASDAQ: LFMD - Get Free Report) have been given an average recommendation of "Moderate Buy" by the nine analysts that are covering the company, MarketBeat.com reports. One anal
LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team
08:00am, Monday, 16'th Mar 2026
NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the appointment of Atul Kavthekar as Chief Financial Offi
LifeMD: Wegovy Pill, Net Cash, And Low Multiple Sets Up Longs For Possible Alpha
03:39pm, Wednesday, 11'th Mar 2026
LifeMD is rated Buy, trading at a low 0.796x TTM sales, with upside if multiples revert. LFMD's strategic divestment of WorkSimpli refocused the business as a pure-play telehealth and pharmacy provide
Uniqure To Rally Around 92%? Here Are 10 Top Analyst Forecasts For Wednesday
08:19am, Wednesday, 11'th Mar 2026
Top Wall Street analysts changed their outlook on top names. See all changes on analyst ratings page.
LifeMD, Inc. (LFMD) Q4 2025 Earnings Call Transcript
06:37pm, Monday, 09'th Mar 2026
LifeMD, Inc. (LFMD) Q4 2025 Earnings Call Transcript
Sign In
Buy LFMD